Health
Sacubitril/valsartan drug did not significantly reduce cardiovascular death after heart attack – News-Medical.Net
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to…
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin-converting enzyme(ACE)inhibitor proven effective in improving survival following heart attacks. Findings from the PARADISE-MI trial were presented at the American College of Cardiologys 70thAnnual Scientific Session.
The study is the first large trial to examine whether sacubitril/valsartan can reduce heart failure…
-
General20 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
General20 hours agoTariff letters to 12 countries going out Monday: Trump
-
Noosa News22 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Noosa News23 hours agoFormer child abuse detective says some Australian daycare centres putting profit over safety